|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$901.26 |
$908.81 |
$891.67 |
$893.99 |
450.60K | 04/19/2024 |
$913.97 |
$920.73 |
$891.46 |
$896.82 |
507.50K | 04/22/2024 |
$904.54 |
$908.67 |
$897.45 |
$900.16 |
351.40K | 04/23/2024 |
$905.66 |
$912.74 |
$903.83 |
$907.32 |
341.20K | 04/24/2024 |
$906.90 |
$915.70 |
$904.41 |
$906.54 |
373.60K |
|
Regeneron Pharmaceuticals is a biotechnology company. Co.'s products include: EYLEA, which is designed for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema, myopic choroidal neovascularization, diabetic retinopathy, neovascular glaucoma and retinopathy of prematurity; Dupixent, which is designed for the treatment of atopic dermatitis, asthma, rhinosinusitis with nasal polyposis, eosinophilic esophagitis (in adults and adolescents) and prurigo nodularis; and Libtayo, which is designed for the treatment of metastatic or locally advanced first-line non-small cell lung cancer and metastatic or recurrent second-line cervical cancer. | |
|
Regeneron Pharmaceuticals (REGN) has the following price history information. Looking back at REGN historical stock prices for the last five trading days, on April 18, 2024, REGN opened at $901.26, traded as high as $908.81 and as low as $891.67, and closed at $893.99. Trading volume was a total of 450.60K shares. On April 19, 2024, REGN opened at $913.97, traded as high as $920.73 and as low as $891.46, and closed at $896.82. Trading volume was a total of 507.50K shares. On April 22, 2024, REGN opened at $904.54, traded as high as $908.67 and as low as $897.45, and closed at $900.16. Trading volume was a total of 351.40K shares. On April 23, 2024, REGN opened at $905.66, traded as high as $912.74 and as low as $903.83, and closed at $907.32. Trading volume was a total of 341.20K shares. On April 24, 2024, REGN opened at $906.90, traded as high as $915.70 and as low as $904.41, and closed at $906.54. Trading volume was a total of 373.60K shares.
REGN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Regeneron Pharmaceuticals shares, starting with a $10,000 purchase of REGN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$281.26 |
|
End price/share: |
$906.54 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
222.31% |
|
Average Annual Total Return: |
12.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$32,232.69 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $893.99 | 04/19/2024 | $896.82 | 04/22/2024 | $900.16 | 04/23/2024 | $907.32 | 04/24/2024 | $906.54 |
|
|